Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4 on the page, indicating a routine update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-05-21T16:28:38.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan District, Taiwan to Taoyuan, Taiwan, keeping the same postal code. This clarifies the exact city-level location for that recruitment site.
    Difference
    0.0%
    Check dated 2026-05-07T09:59:41.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.2 to v3.5.3, indicating a minor version update to the page rendering rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-04-30T08:44:38.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T02:13:09.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.0 appears on the page, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T07:31:53.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed. This update concerns metadata only and does not alter the study details or user-facing content on the page.
    Difference
    0.0%
    Check dated 2026-03-10T14:57:30.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.